Page last updated: 2024-09-04

naproxen and 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid

naproxen has been researched along with 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid in 1 studies

Compound Research Comparison

Studies
(naproxen)
Trials
(naproxen)
Recent Studies (post-2010)
(naproxen)
Studies
(5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid)
Trials
(5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid)
Recent Studies (post-2010) (5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid)
4,5511,0571,4291839126

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbasinazari, M; Abdi, S; Ahmadpour, F; Dabir, S; Fatehi, S; Hatami, B; Mohammad Alizadeh, AH; Nematollahi, A; Pourhoseingholi, MA1

Trials

1 trial(s) available for naproxen and 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid

ArticleYear
Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:3

    Topics: Administration, Rectal; Adult; Aged; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Incidence; Indomethacin; Iran; Lipase; Lipoxins; Male; Middle Aged; Naproxen; Pancreatitis; Risk Factors; Time Factors; Treatment Outcome

2017